Emami Limited Showcases Strong Recovery with 11% Growth in Q3FY26
Emami Limited presented strong operational performance in its investor presentation, highlighting 7% domestic sales growth in FY25 and robust 11% growth in Q3FY26. The company successfully transformed its portfolio from niche to mainstream segments, with new age products increasing from 7% to 20% share. D2C brands revenue nearly doubled from FY23 to FY25, while international business maintained 11% five-year CAGR despite challenges. Key brands including Navratna, Dermicool, BoroPlus, and Zandu Healthcare delivered strong double-digit growth, supported by strategic brand rejuvenations and digital transformation initiatives.

*this image is generated using AI for illustrative purposes only.
Emami Limited presented its comprehensive investor presentation for the Nuvama India Conference 2026 and IIFL's 17th Enterprising India Global Investors' Conference, showcasing strong operational performance and strategic growth initiatives across its diversified portfolio.
Strong FY25 Performance Despite Market Challenges
The company delivered resilient performance in FY25 despite facing higher inflation and subdued rural demand. Emami demonstrated strong cost discipline and agile execution while gaining market share across key categories.
| Performance Metric | FY25 Growth |
|---|---|
| Domestic Net Sales (Value) | +7% |
| Domestic Net Sales (Volume) | +4% |
| International Net Sales (Constant Currency) | +5% |
| International Net Sales (INR) | +4% |
| EBIDTA | +8% |
| Profit Before Tax | +13% |
| Profit After Tax | +11% |
Key brands delivered exceptional growth with Navratna and Dermicool growing by 18%, BoroPlus expanding by 14%, and Zandu Healthcare achieving 12% growth. The company's margin expansion was driven by cost optimization and premiumization strategies, with gross margins improving by 100 basis points and EBIDTA margins expanding by 40 basis points.
Strategic Portfolio Transformation
Emami's core brands have successfully diversified from niche segments into mainstream categories. The company's new age and mainstream portfolio share increased significantly from 7% in FY20 to 20% in FY25 for domestic business.
| Brand Category | FY20 New Age Share | FY25 New Age Share |
|---|---|---|
| BoroPlus | 9% | 23% |
| Kesh King | 23% | 41% |
| Smart and Handsome | 13% | 17% |
| Healthcare | 4% | 26% |
The company has undertaken significant brand rejuvenations, including relaunching Kesh King as Kesh King Gold with new formulation and positioning, and rebranding Fair & Handsome to Smart & Handsome to expand into the grooming universe worth ₹6,700 crore.
Digital and D2C Growth Momentum
Emami's D2C brands revenue nearly doubled in FY25 compared to FY23, with gross margins improving dramatically from 47.2% in FY23 to 60.2% in FY25. The company's digital transformation includes strategic investments in startups and expansion of organized channel presence.
| Channel Development | FY20 | FY25 |
|---|---|---|
| Organized Channels Share | 11% | 29% |
| E-Commerce Share | 0% | 12% |
| Modern Trade Share | 7% | 11% |
ZanduCare, the company's digital healthcare ecosystem, has shown impressive growth with approximately 100 digital-first products launched and 3.2x sales growth from FY21 to FY25. The platform has served over 21 lakh cumulative orders and achieved cumulative GMV of approximately ₹120 crore.
International Business Resilience
Despite geopolitical challenges, Emami's international business maintained steady performance with 11% five-year CAGR. The business accounts for 17% of total revenue in FY25, up from 15% in FY20. The company has strategically localized operations with 80% production and sourcing now outside India and 85% of international workforce locally hired.
Strong Q3FY26 Recovery
After facing challenges in H1FY26 due to weak summers, unseasonal rains, and GST transition impacts, Emami delivered strong 11% growth in Q3FY26. The quarter showed robust performance across the portfolio with strong growth in key brands including BoroPlus, Zandu, Mentho Plus Balm, Kesh King Gold, Navratna, Dermicool, Smart and Handsome, and The Man Company.
| Quarter Performance | Growth Rate | Key Impact Factors |
|---|---|---|
| Q1FY26 | 0% | Weak summers and unseasonal rains |
| Q2FY26 | -10% | GST transition and excess rainfall |
| Q3FY26 | 11% | Strong growth across portfolio |
Financial Strength and Capital Allocation
Emami maintains strong financial health with disciplined capital deployment. From FY21 to 9MFY26, the company distributed ₹2,024 crore in cumulative dividends, conducted ₹663 crore in cumulative buybacks, and invested approximately ₹985 crore in cumulative acquisitions and strategic investments. The company holds over ₹1,000 crore in net cash as of 31st December 2025, reinforcing its ability to fund growth while rewarding shareholders.
Historical Stock Returns for Emami
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.21% | +5.00% | -4.27% | -17.86% | -13.87% | +0.33% |

































